Neoplasms
📧 Sign up to get email alerts when something new happens for Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-25EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd
The EMA authorised Akynzeo (netupitant and palonosetron hydrochloride) for vomiting, nausea, cancer-related indications.
-
CLINICAL_TRIALS research · 2026-08-17Clinical Trial Results: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
A completed clinical trial examines pre-diagnosis GLP-1 receptor agonist use and post-cancer mortality in adults with obesity and type 2 dia…
-
EMA approval · 2026-08-06EMA Authorised: Thiotepa Riemser (thiotepa) — Esteve Pharmaceuticals GmbH
The EMA has authorised Thiotepa Riemser (thiotepa) for hematopoietic stem cell transplantation and neoplasms, with Esteve Pharmaceuticals Gm…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors [Phase 1]
The document reports the completed Phase I trial of TdCyd (4'-Thio-2'-Deoxycytidine) in patients with advanced solid tumors, sponsored by th…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and clofarabine in adults with relapsed solid tumors has been completed. The listed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event [NA]
ClinicalTrials.gov update describes a study on continuous temperature monitoring to detect cytokine release syndrome during immunotherapy, w…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
This clinical trial update describes the collection of tissue specimens from patients with solid tumors or hematologic neoplasms and their H…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients [NA]
Completed clinical trial evaluating a nature-based virtual reality intervention for family caregivers of allogeneic hematopoietic stem cell …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
National Cancer Institute-funded clinical trial has completed, evaluating machine learning analysis of facial imaging, voice, and spoken lan…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Collection of Tissue Samples for Cancer Research
This recruiting trial aims to collect tissue samples for cancer research, sponsored by the National Cancer Institute. It encompasses neoplas…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
A completed clinical trial update evaluating whether pre-diagnosis use of GLP-1 receptor agonists is associated with post-cancer mortality i…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
An ongoing long-term safety follow-up study in paediatric participants with growth hormone deficiency treated with somapacitan to monitor sa…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors) [Phase 1]
Phase 1 trial evaluating different doses of Brigimadlin (BI 907828) in patients with advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes LRK-4189 being studied for safety, tolerability, and preliminary efficacy in patients with solid tumors…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel [Phase 2]
Phase 2 trial update for a combination of nilotinib and paclitaxel in rare tumors; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and preliminary efficacy of GSK5460025 alone or in combination …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Clinical and Genetic Studies of Li-Fraumeni Syndrome
Ongoing clinical and genetic studies on Li-Fraumeni syndrome, a TP53 mutation–associated cancer predisposition, with recruitment currently o…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of E7386 in Participants With Selected Advanced Neoplasms [Phase 1]
A status update for Eisai's Phase 1 study of E7386 in participants with selected advanced neoplasms, indicating the trial is currently activ…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study [NA]
A pilot clinical trial evaluating EMDR integrative group and individual treatment for cancer patients, including those with thyroid neoplasm…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study [Phase 1]
An update on an adoptive cell therapy long-term follow-up study (LTFU) for neoplasms. The Phase 1 trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors [Phase 1]
Phase 1 study of JNJ-70218902 in participants with advanced solid tumors has completed.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University is conducting a clinical trial evaluating novel serum markers to monitor response to anti-cancer therapy. The study is c…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer [Phase 1, Phase 2]
A clinical trial update for ACIT-1, a therapeutic vaccine, in cancers, currently in Phase 1/2 and not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Involvement of the Immune System in Intrinsic Radiosensitivity [NA]
Update on an ongoing clinical trial exploring the involvement of the immune system in intrinsic radiosensitivity in neoplasms.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors [Phase 1]
A first-in-human Phase 1 study of GSK3745417 in participants with advanced solid tumors has results posted; the trial is currently active bu…